To test whether the anti-invasive effect of paeoniflorin depends on the degradation of BACH1 via FBXO22, we repeated the invasion experiments with paeoniflorin in both FBXO22-proficient and -deficient lung cancer cells. The gene discussed is FBXO22; the disease is lung carcinoma.